In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Vioxx Withdrawal: Can the Industry Avoid the Whirlpool?

Executive Summary

The Vioxx withdrawal is one of those seminal events that, because of the players involved--the industry's largest companies, some of their most valuable drugs, both the European and American regulatory structures--holds up a mirror to an entire industry. Given the record breaking valuation slides, the market is taking a very critical look at the industry's strategies; so should the people who run it.

Related Content

The Shake Up At Endo Pharma
The Unsung Vytorin Victim: Primary-Care Marketing
A Little Knowledge: The FDA's Public Approach to Safety
Pfizer's Analyst Day: And Now, For Its Next Trick
Message Problems: One Key Lesson from the Cox-2 Advisory Panel
Drug Safety, the Sequel: This Time It's Specialist Products
Cyberizing the Rep: Can E-Marketing Solve Pharma's Promotional Dilemma?
The Anti-Global, Specialist Strategy: Why Bayer's Choice Might Be Right for Other Pharmas
Endo: Accessing Primary Care through Specialist Marketing
The Winners Post-Vioxx: Merck's Product-Focused Biotechs


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts